naloxone IV
Selected indexed studies
- Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. (Clin Pharmacokinet, 2024) [PMID:38485851]
- High-dose naloxone formulations are not as essential as we thought. (Harm Reduct J, 2024) [PMID:38741224]
- Modifying naloxone to reverse fentanyl-induced overdose. (Int J Pharm, 2022) [PMID:34848365]
_Worker-drafted node — pending editorial review._
Connections
naloxone IV is a side effect of
Sources
- Modifying naloxone to reverse fentanyl-induced overdose. (2022) pubmed
- Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. (2024) pubmed
- High-dose naloxone formulations are not as essential as we thought. (2024) pubmed
- Naloxone-induced pulmonary edema. (1987) pubmed
- Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: a meta-analysis. (2011) pubmed
- Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. (2007) pubmed
- Pitfalls of intranasal naloxone. (2014) pubmed
- Prehospital Naloxone Administration Patterns during the Era of Synthetic Opioids. (2024) pubmed
- Chronic ethanol intake-induced changes in open-field behavior and calcium/calmodulin-dependent protein kinase IV expression in nucleus accumbens of rats: naloxone reversal. (2008) pubmed
- Naloxone reversal of oxymorphone effects in dogs. (1989) pubmed